Related Experiment Video
Updated: Nov 26, 2025

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
Management of Pleural Infection
Anand Sundaralingam1, Radhika Banka2, Najib M Rahman2,3,4
1Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Anand.Sundaralingam@ouh.nhs.uk.
Pleural infection, often linked to pneumonia, presents treatment challenges. Advanced therapies like intrapleural fibrinolysin and DNase, alongside personalized approaches, show promise in improving outcomes for complicated effusions and empyema.
Area of Science:
- Pulmonology
- Infectious Diseases
- Thoracic Surgery
Background:
- Pleural infection, frequently associated with pneumonia, poses significant clinical challenges.
- Pleural effusions occur in 14% (CXR) to 44% (ultrasound) of pneumonia cases, often resolving with antibiotics.
- Treatment strategies are guided by effusion characteristics, but causative organisms vary geographically and by healthcare setting.
Purpose of the Study:
- To review current and emerging treatment modalities for pleural infection, including complicated parapneumonic effusions and empyema.
- To highlight advancements in diagnostic yields and therapeutic efficacy.
- To explore personalized medicine approaches in pleural infection management.
Main Methods:
- Review of existing literature and clinical trial data, including the Multi-centre Intrapleural Sepsis Trials (MIST).
- Analysis of diagnostic techniques, microbiological culture yields, and imaging modalities (CXR, ultrasound).
- Evaluation of therapeutic interventions: antibiotics, tube thoracostomy, intrapleural agents, and surgical options.
Main Results:
- Empirical antibiotic therapy requires broad coverage (Gram-positive, Gram-negative, anaerobic) with adequate pleural penetration.
- Next-generation sequencing may improve microbiological diagnostic yields.
- Combination intrapleural fibrinolysin and DNase therapy demonstrates high success rates (approx. 90%) for empyema.
- Tube thoracostomy failure rates necessitate escalation in 16-27% of cases.
Conclusions:
- Personalized therapy, adjusting intrapleural agent dosage based on 'fibrinolytic potential', is a key future direction.
- While surgery remains crucial for late-stage disease, its role in early stages requires re-evaluation.
- Adjunct therapies like thoracoscopy, indwelling catheters, and intrapleural antibiotics offer additional management options.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pleura of the Lungs
Pleural Disorders: Types and Brief Description

